PEN
Penumbra Inc
NYSE: PEN · HEALTHCARE · MEDICAL DEVICES
$324.82
-0.36% today
Updated 2026-04-29
Market cap
$12.79B
P/E ratio
71.96
P/S ratio
9.11x
EPS (TTM)
$4.53
Dividend yield
—
52W range
$221 – $362
Volume
0.6M
Penumbra Inc (PEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$324.82
12-Month target
$135.82
2030 Target
—
Intrinsic (DCF)
$342.97
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.8B | $1.1B | $1.2B | $1.4B | $1.7B | $2.0B | $2.4B | $2.9B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 12.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.